
Tom Crabtree
@tomcrabtree90
Diabetes & Endocrine Cons/ Pathologically enthusiastic / Ex-YDEF 🪑/🍷 🏃♂️ 🧀 🧳 / All the technology & real-world stuff / He/Him 🏳️🌈
ID: 1102641394332635137
04-03-2019 18:46:09
2,2K Tweet
1,1K Followers
677 Following


Time in range or time in tight range? What matters to you? If you have T1DM please spare a few moments to complete this important survey: redcap.link/su3jl5co Katharine Barnard-Kelly David Kerr


“#T1Diabetes in care homes: A practical guide on management” An article worth a read Via Srikanth Bellary Giuseppe Maltese et al via Diabetic Medicine #T1D certainly no longer “just in the young” Prof Kamlesh Khunti Link: onlinelibrary.wiley.com/doi/10.1111/dm…



Our paper on the management of diabetes‐related hyperglycaemic emergencies in advanced chronic kidney disease is out today. Joint British Diabetes Societies – Inpatient Care Omar Mustafa onlinelibrary.wiley.com/doi/10.1111/dm…



Trying to do e-mails in the taxi from the airport home… replied to a large group of very well renowned international Diabetologists. Signed off with a typo “beer wishes”. Can’t cope… I think I have made Emma Wilmot’s day Need the ground to swallow me up 🫠🫠





The NICE TA 943 came out in December 23 Based on the 'Hybrid Closed Loop' Pilot study done via NHS England How did they all do? Thank you Alexandros Liarakos Tom Crabtree Tomás Griffin et al for leading on this work Summary: ⬇️ HbA1c ⬆️ Time In Range ⬇️ Diabetes


🤩NEW article & podcast in the Journal of Diabetes Nursing with John Pemberton “Making sense of sensors & how to evaluate them” ❓Should cost override safety data? ❓How can we understand what’s safe? ❓Is MARD a useful measurement? 🔗 diabetesonthenet.com/journal-diabet… #gbdoc




The legacy effect of early HbA1c control on microvascular complications and hospital admissions in type 2 diabetes Rami | رامي بن دعفس Tom Crabtree Uni of Nottingham School of Medicine #WeAreUoN University Hospitals of Derby and Burton NHS FT journals.sagepub.com/doi/10.1177/20…